albendazole sulfoxide has been researched along with Central Nervous System Cysticercosis in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Alves, DSMM; Costa, TL; Fraga, CM; Isac, E; Lima, NF; Lino Junior, RS; Picanço, GA; Vinaud, MC | 1 |
| Carrillo-Mezo, R; Fleury, A; González-Hernández, I; Jung, H; Matus, C; Osorio, R; Romo, ML; Toledo, A | 1 |
| Arroyo, G; Bonato, PS; Bustos, JA; Garcia, HH; Gilman, RH; Gonzales, I; Gonzalez, AE; Horton, J; Lanchote, VL; Lescano, AG; Pretell, EJ; Rodriguez, S; Saavedra, H; Takayanagui, OM | 1 |
| Bharkad, GP; Devarajan, PV; Shinde, RL | 1 |
| Brundage, RC; Castro, N; Góngora, F; González-Esquivel, D; Jara, A; Jung, H; Lanao, JM; Márquez-Caraveo, C; Suárez, AM; Urizar, J | 1 |
| Cárdenas, G; González-Hernández, I; Jung-Cook, H; Ruiz-Olmedo, MI | 1 |
| Cass, QB; de Campos Lourenço, T; Dorny, P; García, HH; Guerra-Giraldez, C; Mahanty, S; Marzal, M; Nash, TE; Paredes, A; Rivera, A | 1 |
| Bonato, PS; Dreossi, SA; Lanchote, VL; Takayanagui, OM | 1 |
| Lanchote, VL; Mateus, FH; Takayanagui, OM | 1 |
| Bonato, PS; Lanchote, VL; Marques, MP; Santos, SR; Takayanagui, OM | 1 |
| Dreossi, SA; Garcia, FS; Lanchote, VL; Takayanagui, OM | 1 |
2 trial(s) available for albendazole sulfoxide and Central Nervous System Cysticercosis
| Article | Year |
|---|---|
Enantioselective kinetic disposition of albendazole sulfoxide in patients with neurocysticercosis.
Topics: Adolescent; Adult; Aged; Albendazole; Anthelmintics; Area Under Curve; Chromatography, High Pressure Liquid; Female; Humans; Male; Middle Aged; Neurocysticercosis; Spectrometry, Fluorescence; Stereoisomerism | 1999 |
Pharmacokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis.
Topics: Adult; Albendazole; Anthelmintics; Anticonvulsants; Area Under Curve; Carbamazepine; Chromatography, High Pressure Liquid; Drug Administration Schedule; Drug Interactions; Female; Humans; Isomerism; Male; Neurocysticercosis; Phenobarbital; Phenytoin | 2002 |
9 other study(ies) available for albendazole sulfoxide and Central Nervous System Cysticercosis
| Article | Year |
|---|---|
In vitro nitazoxanide exposure affects energetic metabolism of Taenia crassiceps.
Topics: Albendazole; Analysis of Variance; Animals; Anthelmintics; Antiparasitic Agents; Citrates; Citric Acid Cycle; Culture Media; Cysticercus; Energy Metabolism; Fumarates; Ketoglutaric Acids; Malates; Neurocysticercosis; Nitro Compounds; Oxaloacetic Acid; Succinic Acid; Taenia; Thiazoles | 2020 |
Factors Associated With Cysticidal Treatment Response in Extraparenchymal Neurocysticercosis.
Topics: Adult; Age Factors; Albendazole; Anthelmintics; Dexamethasone; Drug Therapy, Combination; Female; Humans; Longitudinal Studies; Male; Middle Aged; Neurocysticercosis; Prednisone; Treatment Outcome | 2019 |
Albendazole Sulfoxide Plasma Levels and Efficacy of Antiparasitic Treatment in Patients With Parenchymal Neurocysticercosis.
Topics: Adolescent; Adult; Aged; Albendazole; Anthelmintics; Chromatography, High Pressure Liquid; Female; Humans; Male; Mass Spectrometry; Middle Aged; Neurocysticercosis; Praziquantel; Young Adult | 2019 |
Intranasal microemulsion for targeted nose to brain delivery in neurocysticercosis: Role of docosahexaenoic acid.
Topics: Administration, Intranasal; Albendazole; Animals; Anthelmintics; Anti-Inflammatory Agents, Non-Steroidal; Blood-Brain Barrier; Brain; Curcumin; Docosahexaenoic Acids; Drug Combinations; Drug Compounding; Drug Delivery Systems; Drug Stability; Emulsions; Female; In Vitro Techniques; Male; Nasal Absorption; Neurocysticercosis; Neurons; Pharmaceutical Vehicles; Rats, Sprague-Dawley; Sheep, Domestic; Tissue Distribution | 2015 |
Population pharmacokinetics of albendazole in patients with neurocysticercosis.
Topics: Adolescent; Adult; Aged; Albendazole; Anthelmintics; Biological Availability; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Humans; Male; Middle Aged; Models, Biological; Neurocysticercosis; Nonlinear Dynamics; Prospective Studies; Young Adult | 2009 |
A simple LC-MS/MS method to determine plasma and cerebrospinal fluid levels of albendazole metabolites (albendazole sulfoxide and albendazole sulfone) in patients with neurocysticercosis.
Topics: Albendazole; Anthelmintics; Chromatography, Liquid; Drug Stability; Humans; Linear Models; Neurocysticercosis; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2012 |
In vitro analysis of albendazole sulfoxide enantiomers shows that (+)-(R)-albendazole sulfoxide is the active enantiomer against Taenia solium.
Topics: Albendazole; Alkaline Phosphatase; Animals; Anticestodal Agents; Neurocysticercosis; Praziquantel; Stereoisomerism; Swine; Taenia solium | 2013 |
Enantioselective distribution of albendazole metabolites in cerebrospinal fluid of patients with neurocysticercosis.
Topics: Adult; Albendazole; Anthelmintics; Brain Diseases; Female; Humans; Male; Middle Aged; Neurocysticercosis; Stereoisomerism | 2002 |
Enantioselective renal excretion of albendazole metabolites in patients with neurocysticercosis.
Topics: Adult; Albendazole; Female; Humans; Kidney; Kinetics; Male; Middle Aged; Molecular Structure; Neurocysticercosis; Stereoisomerism | 2004 |